Sanjiv Lal: The Personal Mission Behind Regen Therapy

Scientist, entrepreneur, and company builder, Sanjiv Lal is bringing two decades of healthcare experience to a deeply personal ambition: helping credible regenerative science reach further.

Sanjiv Lal knows healthcare as a scientist, an entrepreneur, and someone who has faced a significant health challenge of his own.

Each perspective brings a different question. What does the science reveal? What is required to build around it? And what does progress mean to the person still searching for answers?

For Lal, those questions have become closely connected. As CEO and Co-Founder of Regen Therapy, he is pursuing a vision of regenerative medicine in which scientific understanding, operational discipline, and accessibility advance together.

His professional background stretches across pharmaceuticals, biotechnology, molecular genetics, diagnostics, laboratory sciences, investing, and entrepreneurship. Yet the purpose behind his current work cannot be explained by a résumé alone. It also reflects a personal experience that brought the possibilities and limitations of healthcare into sharper focus.

That combination of professional knowledge and personal urgency gives his story its direction. Lal is interested not only in what regenerative science might make possible, but also in the work required to develop that potential responsibly.

A Scientific Foundation, an Entrepreneurial Instinct

Lal earned both his Bachelor of Science and Master of Science in Pharmaceutical Sciences from The Ohio State University. That education provided the foundation for a career spent moving between scientific disciplines and the practical demands of building businesses.

Over more than two decades, he has founded and scaled multiple healthcare and laboratory companies, including three laboratory businesses, with two successful exits.

His experience encompasses more than launching ventures. It includes the work of turning specialized knowledge into organizations that can operate, develop, and grow.

That distinction is central to the perspective he brings to Regen Therapy. A promising scientific idea and a functioning healthcare enterprise are not the same achievement. Connecting them requires attention to research, manufacturing, infrastructure, education, and the people responsible for carrying the work forward.

Lal’s career has given him exposure to these different responsibilities. His scientific training informs the questions he asks. His entrepreneurial experience shapes how he approaches the challenge of building around the answers.

When Healthcare Became Personal

A significant health challenge changed the way Lal engaged with regenerative medicine.

In navigating his own experience, he found that conventional approaches could only take him so far. His search for further answers introduced him to regenerative science and prompted him to look more closely at the field surrounding it.

What he encountered was not a simple story of possibility. Alongside scientific potential, he saw gaps in access, education, manufacturing consistency, clinical infrastructure, and credibility.

These concerns helped shape the founding thesis behind Regen Therapy.

For Lal, the experience connected an individual search with a larger set of questions. How could the science be better understood? What infrastructure was missing? How could physicians become better informed? And what would make credible regenerative healthcare less fragmented and more accessible?

His personal journey did not replace his scientific perspective. It gave that perspective a more immediate purpose.

The result is a mission that recognizes both the appeal of new possibilities and the responsibility involved in developing them.

Paying Attention to the Conversation Between Cells

Among Lal’s strongest scientific interests today are secretome science and cellular signaling.

His focus includes the complex network of proteins, growth factors, cytokines, chemokines, extracellular vesicles, and other biological signals involved in communication between cells.

He believes that the next evolution of regenerative medicine will require looking beyond cells themselves to understand more fully the information exchanged between them.

It is a perspective that directs attention toward communication, interaction, and biological complexity. Rather than concentrating only on the presence of cells, Lal is interested in the signals they produce and the questions those signals raise for regenerative research.

Just as importantly, his priorities extend to the foundations needed to investigate and develop that science: characterization, manufacturing, research, and physician education.

In his vision, those are not secondary considerations. They are essential parts of responsible progress.

The scientific possibilities are what draw his attention. The work of understanding, evaluating, and building around them is what defines his approach.

Bringing Different Kinds of Expertise Together

Lal’s interests reach beyond any single area of healthcare.

Longevity, diagnostics, mitochondrial health, biotechnology, artificial intelligence, and increasingly personalized healthcare all form part of his broader professional focus. He regularly brings together physicians, researchers, founders, investors, and industry leaders to encourage collaboration across disciplines.

That collaborative instinct is reflected in the range of roles he holds.

Alongside Regen Therapy, Lal is Co-Founder and Partner at Motivant, owner of Beverly Hills Rejuvenation Center, and a Board Advisor to Carl X Dimes. His broader work also includes involvement with XPRIZE initiatives focused on health and human performance.

These activities connect him with different perspectives on innovation. Researchers may be examining biological questions. Physicians bring clinical considerations. Founders work through execution. Investors evaluate the resources and structures needed to support development.

Lal’s interest lies in encouraging those conversations to happen together rather than in isolation.

His career has crossed enough professional boundaries to make that collaboration a natural extension of his work. He is comfortable engaging with the science while also considering the organizational and entrepreneurial demands surrounding it.

Making Access Part of the Ambition

At the center of Lal’s mission is the goal of democratizing regenerative medicine.

He wants to help move credible regenerative science beyond access that is fragmented, expensive, and highly specialized. His ambition is to support a future in which stronger science, better infrastructure, and broader education make next-generation regenerative healthcare more scalable and accessible.

This remains a goal to work toward, rather than a claim that the field’s challenges have already been resolved.

What distinguishes his stated vision is the connection he draws between access and the foundations that support it. Broader availability, in his approach, must be considered alongside scientific credibility, manufacturing consistency, research, and education.

The mission is therefore larger than introducing people to an emerging field. It is about helping build the conditions under which that field can develop more responsibly.

For Lal, accessibility is not separate from the scientific work. It is one of the reasons to pursue that work with greater rigor.

A Career With a More Personal Definition of Progress

Sanjiv Lal’s journey brings together accomplishments that are easy to list and motivations that require a closer look.

There are the degrees, the companies, the exits, and the expanding network of entrepreneurial and advisory roles. Then there is the personal experience that helped turn a professional interest into a more focused mission.

Regen Therapy sits where those parts of his story meet.

Lal brings the curiosity of a scientist, the practical perspective of a business builder, and the urgency of someone who understands the search for answers firsthand. His ambition is to use that combination to strengthen the connection between regenerative research and the infrastructure needed to support its future.

The next chapter of his work is not defined simply by what might be discovered. It is defined by what must be understood, built, and made accessible.

For Sanjiv Lal, that is where scientific ambition becomes a human mission